Wednesday, November 15, 2017

US FDA News: FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

Newly authorized test detects genetic cancer mutations in 468 unique genes
Read more: FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action